Journal article · 2023

Description and In silico ADME Studies of US-FDA Approved Drugs or Drugs under Clinical Trial which Violate the Lipinski’s Rule of 5

Niyatha Lohit, Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, Jagat Pal Yadav, Kuldeep Singh, Pradeep Kumar

Letters in Drug Design & Discovery, 21(8), 1334–1358 · Published 24 February 2023 · DOI 10.2174/1570180820666230224112505

View at the publisherCite this paper

In brief

“Description and In silico ADME Studies of US-FDA Approved Drugs or Drugs under Clinical Trial which Violate the Lipinski’s Rule of 5” is a 2023 journal article by Niyatha Lohit and 6 co-authors, published in Letters in Drug Design & Discovery. OpenAlex counts 74 citations as of 15 November 2026, which puts it in the top 2% of works published in 2023 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
74
Most cited in
2026 (35)
Field-weighted impact
6.38
References
130
Authors
7

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Lohit, N., Singh, A. K., Kumar, A., Singh, H., Yadav, J. P., Singh, K., & Kumar, P. (2023). Description and In silico ADME Studies of US-FDA Approved Drugs or Drugs under Clinical Trial which Violate the Lipinski’s Rule of 5. Letters in Drug Design & Discovery, 21(8), 1334–1358. https://doi.org/10.2174/1570180820666230224112505

MLA 9

Lohit, Niyatha, et al. “Description and In silico ADME Studies of US-FDA Approved Drugs or Drugs under Clinical Trial which Violate the Lipinski’s Rule of 5.” Letters in Drug Design & Discovery, vol. 21, no. 8, 2023, pp. 1334–1358. https://doi.org/10.2174/1570180820666230224112505.

Chicago

Lohit, Niyatha, Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, Jagat Pal Yadav, Kuldeep Singh, and Pradeep Kumar. 2023. “Description and In silico ADME Studies of US-FDA Approved Drugs or Drugs under Clinical Trial which Violate the Lipinski’s Rule of 5.” Letters in Drug Design & Discovery 21 (8): 1334–1358. https://doi.org/10.2174/1570180820666230224112505.

Harvard

Lohit, N. et al. (2023) ‘Description and In silico ADME Studies of US-FDA Approved Drugs or Drugs under Clinical Trial which Violate the Lipinski’s Rule of 5’, Letters in Drug Design & Discovery, 21(8), pp. 1334–1358. doi:10.2174/1570180820666230224112505.

IEEE

N. Lohit et al., “Description and In silico ADME Studies of US-FDA Approved Drugs or Drugs under Clinical Trial which Violate the Lipinski’s Rule of 5,” Letters in Drug Design & Discovery, vol. 21, no. 8, pp. 1334–1358, 2023, doi: 10.2174/1570180820666230224112505.

BibTeX

@article{lohit2023description,
  title     = {{Description and In silico ADME Studies of US-FDA Approved Drugs or Drugs under Clinical Trial which Violate the Lipinski’s Rule of 5}},
  author    = {Lohit, Niyatha and Singh, Ankit Kumar and Kumar, Adarsh and Singh, Harshwardhan and Yadav, Jagat Pal and Singh, Kuldeep and Kumar, Pradeep},
  journal   = {Letters in Drug Design \& Discovery},
  year      = {2023},
  volume    = {21},
  number    = {8},
  pages     = {1334--1358},
  doi       = {10.2174/1570180820666230224112505},
  url       = {https://doi.org/10.2174/1570180820666230224112505}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202477
20253232
20263535

Its field-weighted citation impact is 6.38: it has been cited 6.38 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • Lipinski's rule of five
  • drug-likeness
  • ADME properties
  • oral bioavailability
  • molecular weight
  • octanol-water partition coefficient
  • hydrogen bond acceptors
  • hydrogen bond donors

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Lohit, N., Singh, A. K., Kumar, A., Singh, H., Yadav, J. P., Singh, K., & Kumar, P. (2023). Description and In silico ADME Studies of US-FDA Approved Drugs or Drugs under Clinical Trial which Violate the Lipinski’s Rule of 5. Letters in Drug Design & Discovery, 21(8), 1334–1358. https://doi.org/10.2174/1570180820666230224112505

How many times has this paper been cited?

74 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Niyatha Lohit, Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, Jagat Pal Yadav, Kuldeep Singh, Pradeep Kumar.

What is the DOI of this paper?

10.2174/1570180820666230224112505. The permanent link is https://doi.org/10.2174/1570180820666230224112505.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.